TD Securities Lowers Dialogue Health Technologies (TSE:CARE) Price Target to C$3.50

Dialogue Health Technologies (TSE:CAREGet Rating) had its target price cut by TD Securities from C$4.50 to C$3.50 in a research note published on Wednesday, BayStreet.CA reports. They currently have a hold rating on the stock.

CARE has been the subject of several other research reports. Royal Bank of Canada reduced their price objective on shares of Dialogue Health Technologies from C$7.00 to C$6.00 and set a sector perform rating for the company in a research note on Monday, August 15th. Scotiabank cut their price target on shares of Dialogue Health Technologies from C$8.50 to C$8.00 in a research note on Friday, August 12th. National Bankshares cut their price target on shares of Dialogue Health Technologies from C$11.50 to C$8.50 and set an outperform rating on the stock in a research note on Tuesday, August 9th. Finally, CIBC lowered shares of Dialogue Health Technologies from an outperform rating to a neutral rating and cut their price target for the company from C$7.00 to C$4.00 in a research note on Tuesday, June 14th.

Dialogue Health Technologies Stock Down 11.1 %

TSE CARE opened at C$2.56 on Wednesday. The company has a debt-to-equity ratio of 2.73, a quick ratio of 3.91 and a current ratio of 4.10. The company has a market cap of C$168.99 million and a price-to-earnings ratio of 5.82. The stock’s 50 day moving average price is C$3.12. Dialogue Health Technologies has a 52 week low of C$2.27 and a 52 week high of C$8.85.

Dialogue Health Technologies Company Profile

(Get Rating)

Dialogue Health Technologies Inc operates a digital healthcare and wellness platform in Canada Germany, and Australia. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists.

Recommended Stories

Receive News & Ratings for Dialogue Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dialogue Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.